[{"address1": "65 Yigal Alon Street", "city": "Tel Aviv", "zip": "6745442", "country": "Israel", "phone": "972 3 717 7050", "website": "https://www.painreform.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Ehud  Geller Ph.D.", "title": "Executive Chairman", "fiscalYear": 2023, "totalPay": 150000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen A. Cooper D.M.D Ph.D.", "title": "Executive Vice President of Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.03, "open": 2.1216, "dayLow": 2.09, "dayHigh": 2.12, "regularMarketPreviousClose": 2.03, "regularMarketOpen": 2.1216, "regularMarketDayLow": 2.09, "regularMarketDayHigh": 2.12, "forwardPE": -0.40820312, "volume": 1742, "regularMarketVolume": 1742, "averageVolume": 23595, "averageVolume10days": 24610, "averageDailyVolume10Day": 24610, "bid": 2.05, "ask": 2.13, "bidSize": 800, "askSize": 900, "marketCap": 3612251, "fiftyTwoWeekLow": 0.417, "fiftyTwoWeekHigh": 26.41, "fiftyDayAverage": 2.23888, "twoHundredDayAverage": 3.147485, "currency": "USD", "enterpriseValue": -4414172, "floatShares": 1209082, "sharesOutstanding": 1728350, "sharesShort": 4798, "sharesShortPriorMonth": 8347, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.0023999999, "heldPercentInsiders": 0.052600004, "heldPercentInstitutions": 0.25530002, "shortRatio": 0.42, "shortPercentOfFloat": 0.0029, "impliedSharesOutstanding": 1728350, "bookValue": 4.188, "priceToBook": 0.49904484, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -9344000, "trailingEps": -7.14, "forwardEps": -5.12, "lastSplitFactor": "1:10", "lastSplitDate": 1688342400, "enterpriseToEbitda": 0.461, "52WeekChange": 2.5789473, "SandP52WeekChange": 0.30279303, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PRFX", "underlyingSymbol": "PRFX", "shortName": "PainReform Ltd.", "longName": "PainReform Ltd.", "firstTradeDateEpochUtc": 1598967000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "cdbb035d-94d1-3758-931b-64e3020464de", "messageBoardId": "finmb_54214693", "gmtOffSetMilliseconds": -18000000, "currentPrice": 2.09, "targetHighPrice": 11.0, "targetLowPrice": 11.0, "targetMeanPrice": 11.0, "targetMedianPrice": 11.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 8026000, "totalCashPerShare": 4.644, "ebitda": -9569000, "totalDebt": 86000, "quickRatio": 3.33, "currentRatio": 4.066, "debtToEquity": 1.188, "returnOnAssets": -0.53823, "returnOnEquity": -1.02344, "freeCashflow": -4364000, "operatingCashflow": -6679000, "financialCurrency": "USD", "trailingPegRatio": null}]